EZH2 and neoplasm: Conversely, disrupting the NLRP6‐p85α interaction has been shown to suppress tumor progression.[47] Our findings provide new insights into the modulation of EZH2 degradation in cancer cells and expand the understanding of the intricate relationship between cellular metabolism and epigenetic regulation.